Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

ANTX AN2 Therapeutics, Inc. Common Stock
$3.49 -4.92% -0.18
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ANTX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 131.5M
Enterprise value 73.5M
Trailing PE -2.0290697674419
Forward PE -4.575
PEG Ratio 0.072708333333333
Enterprise to EBITDA -1.4056532110092
Price to book MRQ 1.8904959

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-09-30
Diluted EPS TTM -1.16
Total Cash (MRQ) 58.0M
Current ratio (MRQ) 6.874
Operating Cash Flow (TTM) -29834000

ANTX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent ANTX News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.